Apontis Pharma AG (FRA:APPH)

Apontis Pharma AG Revenue

In the year 2024, Apontis Pharma AG had annual revenue of 48.47M EUR with 31.12% growth. Apontis Pharma AG had revenue of 25.74M in the half year ending December 31, 2024, a decrease of -4.90%.

• Revenue: 48.47M
• Revenue Growth: +31.12%
• P/S Ratio: 1.86
• Revenue / Employee: 353.78K
• Employees: 137
• Market Cap: 89.96M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	48.47M	11.50M	31.12%
Dec 31, 2023	36.96M	-18.76M	-33.67%
Dec 31, 2022	55.73M	4.54M	8.87%
Dec 31, 2021	51.18M	11.94M	30.44%
Dec 31, 2020	39.24M	-794.91K	-1.99%